What's driving Global Pharma-grade Periodic Acid to USD 211 M API synthesis needs? Global Pharmaceutical-grade Periodic Acid Market was valued at USD 139 million in 2025. The market is projected to grow from USD 148 million in 2026 to USD 211 million by 2034, exhibiting a CAGR of 6.1% during the forecast period. In terms of volume, sales reached 2,407 tons in 2025, with an average price of USD 63.24 per kilogram. Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/300285/pharmaceuticalgrade-periodic-acid-market

Surface Plasmon Resonance Systems: Advancing Label-Free Detection According to a newly published market research report by 24LifeSciences, global Surface Plasmon Resonance (SPR) System market was valued at USD 820 million in 2026 and is projected to reach USD 1.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period. Surface Plasmon Resonance (SPR) is a label-free, real-time optical biosensing technology that enables detailed analysis of biomolecular interactions by detecting changes in refractive index on a sensor surface. This technology provides critical insights into binding kinetics, affinity, and specificity without requiring fluorescent or radioactive labels, making it invaluable across multiple scientific disciplines. Its ability to characterize molecular interactions with exceptional precision continues to drive its adoption in pharmaceutical research, diagnostics development, and academic studies. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10057/surface-plasmon-resonance-spr-system-market

Monoclonal Antibody Custom Service Market Size to Reach USD 1.63 Billion by 2032 Global monoclonal antibody custom service market is entering a phase of sustained expansion as biologics, precision medicine, and translational research reshape modern drug development. Valued at USD 1,055 million in 2024, the market is projected to grow from USD 1,123 million in 2025 to USD 1,634 million by 2032, registering a compound annual growth rate (CAGR) of 6.6% over the forecast period. Increasing reliance on bespoke antibody solutions across biopharmaceutical R&D, diagnostics, and oncology-focused research is reinforcing the strategic importance of custom antibody services worldwide. Access the market report https://www.24lifesciences.com/monoclonal-antibody-custom-service-market-9539

Singleplex Immunoassay Market Size to Reach USD 5.92 Billion by 2030 | Growth Trends & Insights Global singleplex immunoassay market is undergoing robust expansion as precision diagnostics, biomarker-driven research, and personalized medicine gain traction across healthcare and life sciences. Valued at USD 3.52 billion in 2022, the market is projected to grow from USD 3.79 billion in 2024 to USD 5.92 billion by 2030, registering a strong CAGR of 7.7% during the forecast period. This growth highlights the continued reliance on high-specificity, single-analyte testing for clinical diagnostics, pharmaceutical research, and translational medicine worldwide. Access the market report https://www.24lifesciences.com/singleplex-immunoassay-market-9037